Scanadu unveils the first of their medical home diagnostic tools
Using online medical resources to diagnose our various aches and pains is just as likely to send someone rushing to the doctor in the belief they have some incurable, life-threatening disease as it is to put any fears to rest. Medical startup Scanadu, which is based at the NASA-Ames Research Center, is set to provide a set of home diagnostic tools that are designed to let users monitor their health over time and provide a better indication of whether a trip to the doc is actually necessary.
While Scanadu continues working on a tricorder-like device capable of capturing key health metrics and diagnosing a set of 15 diseases in an attempt to claim the $10 million Qualcomm Tricorder X Prize, it has just revealed its first three consumer health products that are designed to put a doctor in your pocket…
The first device in the company’s initial product lineup is the Scanadu SCOUT, a palm-sized device designed by Yves Behar that Scanadu says will accurately read a variety of vital signs when held to the temple for a period of under 10 seconds. Data collected by the device is transmitted via Bluetooth to a smartphone, where the Scanadu app will display pulse transit time, pulse rate, electrical heart activity, temperature, heart rate variability and blood oxygenation. The data can also be transmitted to the user’s doctor. The SCOUT is expected to retail for under $150.
Scanadu’s other two products, which also work in conjunction with Scandu’s smartphone app, are designed as low-cost, disposable diagnostic tools.
Turning a smartphone into a urine analysis reader is the ScanaFlo, which is a disposable cartridge that is designed to be sold over the counter. It will test for complications during pregnancy, preeclampisa, gestational diabetes, kidney failure and urinary tract infections. Scanadu also claims it will be the first consumer device to provide a personal “healthfeed” for the duration of a pregnancy.
Also designed as a disposable cartridge, the third and final entry in Scandu’s initial product line is the ScanaFlu. As its name suggests, the ScanFlu is designed to quickly assess cold-like symptoms, with the ability to test saliva for the early detection of Strep A, Influenza A, Influenza B, Adenovirus and RSV.
All three of these devices should be in production and on the way to consumers before the end of 2013. For someone like me – capable of being a world-class hypochondriac – they should be a delight, useful or otherwise.